BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies' registrational ...
A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
MedPage Today on MSN
Paradigm shift for evaluating, treating biochemical recurrence in prostate cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
Zinzino group revenue increased with a total of 20 %, compared with the previous year. The revenue in January for Zinzino's sales markets increased by 20% and amounted to SEK 274.1 (229.2) million.
Cereno Scientific , an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that it is broadening the ...
In January 2026, Islamic Revolutionary Guard Corps and other security forces of the Islamic Republic of Iran massacred protesters and healthcare workers in a swathe of mass violence.12 The violence ...
MedPage Today on MSN
'Most compelling' data yet for metastasis-directed therapy in prostate cancer
But an association with improved overall survival failed to reach statistical significance ...
Nuclear energy offers a low-carbon footprint and less dependence on fossil fuel, but several materials challenges must be met to advance nuclear technology. The potential of nuclear energy as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results